Meeting Register Page

NCCS Lunch Time CME
Date: 25 March 2022, Friday, from 1pm to 2pm

GP Lunch Time & Case Discussion
Prostate Cancer - Is there a need to adjust chronic disease medications?
1 CME point will be accredited


68 year old Chinese male, with metastatic prostate cancer is on androgen deprivation therapy (ADT) and novel anti androgen therapy. He is planned for radiation treatment to the prostate. He is on regular follow up with his family physician for diabetes and hypertension. At his regular review, he is noted to have worsening sugar and blood pressure control.

Case Discussion and Q&A with our Panelists:

- Dr Tanujaa D/O Rajasekaran, Consultant, Division of Medical Oncology

- Dr Li Youquan, Consultant, Division of Radiation Oncology
Meeting logo
Meeting is over, you can not register now. If you have any questions, please contact Meeting host: NCCS GPNetwork.